Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02420873
What this trial is testing

An Open-label Phase II Study of Lorvotuzumab Mertansine

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 9
Early research (Phase 1)Ended earlyNCT03203369
What this trial is testing

Study to Evaluate the Safety and Clinical Activity of UCART123 in Patients With BPDCN

Who this might be right for
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Cellectis S.A. 1
Testing effectiveness (Phase 2)UnknownNCT03599960
What this trial is testing

Combination Chemotherapy in Patients With Newly Diagnosed BPDCN

Who this might be right for
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Centre Hospitalier Universitaire de Besancon 26
Testing effectiveness (Phase 2)Looking for participantsNCT04216524
What this trial is testing

Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

Who this might be right for
Blastic Plasmacytoid Dendritic Cell Neoplasm
M.D. Anderson Cancer Center 40
Early research (Phase 1)Study completedNCT02730312
What this trial is testing

PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies

Who this might be right for
Acute Myelogenous LeukemiaB-cell Acute Lymphoblastic LeukemiaBlastic Plasmacytoid Dendritic Cell Neoplasm+1 more
Xencor, Inc. 120
Testing effectiveness (Phase 2)Ended earlyNCT04109482
What this trial is testing

Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN.

Who this might be right for
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Mustang Bio 3
Not applicableStudy completedNCT02859623
What this trial is testing

Descriptive Study of the Efficacy of Treatments for Blastic Dendritic Cell Neoplasm (BPDCN)

Who this might be right for
Blastic Plasmacytoid Dendritic Cell NeoplasmHematological Malignancies
Centre Hospitalier Universitaire de Besancon 86